At Home Testing Kits Market Overview
The global at home testing kits market, valued at USD 18.21 billion in 2025, is projected to reach USD 19.24 billion in 2026 and USD 31.15 billion by 2035, with a 5.5% CAGR during the forecast period 2026 to 2035.
To learn more about this report, request a free sample copy
Since the approval of the first over-the-counter test kits in the early 1976, there has been a substantial increase in the development initiatives focused on such products. In this context, it is worth highlighting that over 20 million at-home pregnancy test kits are being annually sold in the US. Companies have also developed at-home diagnostic kits for the detection and diagnosis of various diseases, such as human immunodeficiency virus (HIV) infection, diabetes, Hepatitis C, colon cancer and COVID-19. Specifically, post the onset of COVID-19, there has been an upsurge in the demand for self-testing kits. In fact, in 2021, more than 100 at-home self-testing kits were approved by the USFDA for the diagnosis of COVID-19. The popularity of these kits can be attributed to the fact that they are more reliable, efficient, high yielding, as well as compatible with a broad range of input samples, including blood, cells, tissues, plasma, saliva and microbes.
Given the extensive utilization of at-home testing kits / at home blood test in the diagnosis of a myriad of disease indications, there has been a significant rise in investments in at home testing kits market. Over USD 2.2 billion has been invested in this domain by various government institutions in the US, over the last five years. Further, the current market landscape is consolidated and primarily dominated by the kits being developed to detect pregnancies, blood glucose monitoring and ovulation patterns.
We believe that, with an increase in the number of point-of-care test kits being developed across various therapeutic areas, such as infectious diseases and celiac diseases, and their subsequent commercialization, the opportunities for self-testing kit developers is likely to increase in the foreseen future. At present, efforts are also ongoing to connect at-home diagnostic tests with telemedicine; this is expected to enable a rapid turnaround time. The ongoing innovations in at home testing kits market are anticipated to bring a positive revolution in the healthcare domain. Given the continuous efforts being undertaken by industry players, the at home testing kits market is poised to witness healthy market growth over the forecast period.
Leading At Home Testing Companies Developing Kits
Examples of key companies engaged in the at home testing kits market (which have also been profiled in this market report; the complete list of companies is available in the full report) include ACON Laboratories, AdvaCare Pharma USA, Apex Biotechnology, i-SENS, Oak Tree Health, TaiDoc Technology and VivaCheck Laboratories. This market report includes an easily searchable excel database of all the at home testing companies developing at home medical tests, at home blood test and self-diagnostic test worldwide.
Recent Developments in At Home Testing Kits Market
Several recent developments have taken place in the field of at home testing kits. We have outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that have been outlined in our analysis.
- In March 2025, The FDA granted marketing authorization to Visby Medical for the Visby Medical Women’s Sexual Health Test, the first over-the-counter at-home diagnostic for chlamydia, gonorrhea, and trichomoniasis.
- In March 2025, Ro acquired at-home diagnostic firm Kit in order to expand Ro's at-home sample collection and integrate Kit’s testing into its Workpath diagnostic service for broader primary care support.
- In January 2025, Teal Health raised USD 10 million in a seed finding round to launch Teal Wand™, the first at-home cervical cancer screening kit.
Scope of the Report
The “At Home Testing Kits Market: Industry Trends and Global Forecasts, till 2035” market report features an extensive study of the current market landscape, market size, market share, market forecast, market outlook and future opportunities associated with the at home testing kits market. The market research report also includes an in-depth analysis, highlighting the capabilities of various industry stakeholders engaged in at home testing kits market. Amongst other elements, the market report features:
- A brief overview of at-home self-testing kits, highlighting the key steps involved while performing at-home self-tests. Further, it highlights the types of at-home tests available, and the types of assays used. The chapter also elaborates on the advantages offered by at-home self-testing kits along with the associated challenges. In addition, the chapter provides information on different regulatory authorities across key geographies which are involved in regulating the approval, safety, and sales of at-home self-testing kits and its future perspectives.
- A detailed overview of the current market landscape of companies engaged in the development of at-home self-testing kits, based on several relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters, type of testing procedure (manual and automatic), type of test format (strip, stick, cassette, and others), purpose of testing (cancer screening, pregnancy detection, diabetes monitoring, ketone monitoring, HIV diagnosis, ovulation monitoring, substance abuse monitoring and, others), target therapeutic area (fertility and reproductive health, metabolic disorders, oncological disorders, infectious diseases, hematological disorders, and others), wearability (wearable and non-wearable), analyte procurement method (invasive and non-invasive), biofluid analyzed (blood, saliva, urine, stool, and others), processing time (maximum processing time), kit components (diagnostic component, collection component, lancets, reagents, and other components), regulatory approvals / certifications (CE, ISO, FDA, IVD, and others), kit reusability, availability of data management tools, target analyte detected (hemoglobin, glucose, FSH, LH, hCG, cholesterol, and others), and follow-up consultation requirement.
- A detailed analysis of academic grants that have been awarded to various research institutes for conducting research focused on at-home self-testing kits, since 2019, based on several parameters, such as year of grant award, amount awarded, support period, type of funding institute center, grant application, purpose of grant award, grant activity code, NIH spending category, study section involved, popular NIH departments, recipient organization, regional distribution of recipient organization. Further, the chapter also highlights the popular recipient organizations, (in terms of number of grants and amount awarded) and prominent program officers (in terms of number of grants).
- A detailed competitiveness analysis of at-home self-testing kit manufacturers based on overall experience of the company (in terms of number of years since its establishment), product portfolio strength (in terms of number of at-home self-testing kits offered) and portfolio diversity (in terms of type of test format, type of biofluid analyzed, number of regulatory approvals, kit reusability, accessibility, and number of target analytes).
- Elaborate profiles of prominent players engaged in offering at-home self-testing kits. Each profile includes a brief overview of the company, along with details related to its financial information (if available), information on product portfolio, recent developments and an informed future outlook.
- A Bowman's strategy clock framework to understand the pricing strategy of the at-home self-testing kits offered by a company, along with its competitive position in the market. In addition, it presents the equation devised to calculate the likely price of the at-home self-testing kits based upon its characteristics.
- An estimate of company’s intrinsic value by utilizing comparable company analysis of publicly listed companies based on their current share price, equity value, enterprise value, EBITDA, net income, and revenue.
- An informed estimate of the annual demand (in terms of number of kits) for at-home self-testing kits, across various therapeutic areas, such as fertility and reproductive health, metabolic disorders, infectious diseases, and oncological disorders.
- A detailed analysis based on a proprietary 2×2 representation, highlighting the current market scenario (in terms of existing competition and growth opportunities) across emerging and established market segments.
- An overview of at-home self-testing kits, highlighting the key steps involved while performing at-home self-tests, types of home-tests and types of assays used. The chapter also elaborates on the advantages offered by at-home self-testing kits along with the associated challenges. In addition, the chapter provides information on different regulatory authorities across key geographies which are involved in regulating the approval, safety, and sales of at-home self-testing kits
The key objective of at home testing kits market report is to provide a detailed market analysis in order to estimate the existing market size, market value, statistics and future opportunity for at home testing kits market during the forecast period. We have provided informed estimates on the likely evolution of the market in the short to mid-term and long term, over the forecast period, till 2035. Our year-wise projections of the current and future opportunity have further been segmented on the basis of [A] therapeutic area (fertility and reproductive health, metabolic disorders, infectious diseases, and oncological disorders), [B] type of biofluid analyzed (blood, urine, and stool), [C] type of test format (cassette, strip, stick and others), [D] key geographical regions (North America, Europe, Asia-Pacific, Africa, and South America). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this market research report are in USD, unless otherwise specified.
Frequently Asked Questions
Question 1: What are at home testing kits?
Answer: At home testing kits encompass a diverse array of tests that can be easily performed by the patients at their home. These tests can provide disease diagnosis and monitoring all at the convenience of the patient’s home.
Question 2: How big is the at home testing kits market?
Answer: The at home testing kits market size is estimated to be worth USD 19.24 billion in 2026.
Question 3: What is the projected market growth of the at home testing kits market?
Answer: The at home testing kits market is expected to grow at compounded annual growth rate (CAGR) of 5.5% during the forecast period, till 2035.
Question 4: Who are the leading players in the at home testing kits market?
Answer: Examples of key companies engaged in the at home testing kits market (which have also been profiled in this market report; the complete list of companies is available in the full report) include ACON Laboratories, AdvaCare Pharma USA, Apex Biotechnology, i-SENS, Oak Tree Health, TaiDoc Technology and VivaCheck Laboratories.
Question 5: How many companies provide at home testing kits worldwide?
Answer: Currently, there are over 60 at home testing companies that claim to develop at home testing kits to enable disease diagnosis.
Question 6: How many at home testing kits are presently marketed / under development by industry stakeholders globally?
Answer: Over 510 at home testing kits are currently marketed / under development by key companies worldwide.
Question 7: Which geographies are key hubs for at home testing companies (kit developers)?
Answer: North America is the hub for at home testing companies (kit developers), with nearly 50% of the companies based in the region.
Question 8: When were at home pregnancy tests invented?
Answer: Home pregnancy testing is the most common at home testing kit used globally, with the first kit launched in 1976 after FDA approval.
